Evidence map›Paper›PMID 21771727›Full record

ArticleCarcinogenesis2011

Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.

Khelifa Arab, Laura T Smith, Andreas Gast, Dieter Weichenhan, Joseph Po-Hsien Huang, Rainer Claus, Thomas Hielscher, Allan V Espinosa, Matthew D Ringel, Carl D Morrison and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Role of the bHLH transcription factor TCF21 in development and tumorigenesis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Review
  9. Review
  10. Review
  11. TCF21: a critical transcription factor in health and cancer.Journal of molecular medicine (Berlin, Germany) · 2020
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  18. Article
  19. Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer.International journal of molecular sciences · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Khelifa ArabGerman Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Laura T Smith
Andreas Gast
Dieter Weichenhan
Joseph Po-Hsien Huang
Rainer Claus
Thomas Hielscher
Allan V Espinosa
Matthew D Ringel
Carl D Morrison
Dirk Schadendorf
Rajiv Kumar
Christoph Plass
German Cancer Research Center · DEEpigenomics (Germany) · DEHeidelberg University · DEThe Ohio State University · USRoswell Park Comprehensive Cancer Center · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · US

Funding

GENOMIC SCANNING IN ORAL CANCERR01DE013123 · NIDCR · OHIO STATE UNIVERSITY · PI PLASS, CHRISTOPH · 2000 to 2011
$2.3M
NIDCR NIH HHS DE13123
6 · The paper itself

Abstract

Metastatic melanoma is a fatal disease due to the lack of successful therapies and biomarkers for early detection and its incidence has been increasing. Genetic studies have defined recurrent chromosomal aberrations, suggesting the location of either tumor suppressor genes or oncogenes. Transcription factor 21 (TCF21) belongs to the class A of the basic helix-loop-helix family with reported functions in early lung and kidney development as well as tumor suppressor function in the malignancies of the lung and head and neck. In this study, we combined quantitative DNA methylation analysis in patient biopsies and in their derived cell lines to demonstrate that TCF21 expression is downregulated in metastatic melanoma by promoter hypermethylation and TCF21 promoter DNA methylation is correlated with decreased survival in metastatic skin melanoma patients. In addition, the chromosomal location of TCF21 on 6q23-q24 coincides with the location of a postulated metastasis suppressor in melanoma. Functionally, TCF21 binds the promoter of the melanoma metastasis-suppressing gene, KiSS1, and enhances its gene expression through interaction with E12, a TCF3 isoform and with TCF12. Loss of TCF21 expression results in loss of KISS1 expression through loss of direct interaction of TCF21 at the KISS1 promoter. Finally, overexpression of TCF21 inhibits motility of C8161 melanoma cells. These data suggest that epigenetic downregulation of TCF21 is functionally involved in melanoma progression and that it may serve as a biomarker for aggressive tumor behavior.

Indexed as

DNA MethylationEpigenomicsGene Expression Regulation, NeoplasticAdolescentAdultAgedAged, 80 and overBasic Helix-Loop-Helix ProteinsBlotting, WesternCell CycleCell DifferentiationCell MovementChildChromatin ImmunoprecipitationFemaleGene SilencingBasic Helix-Loop-Helix ProteinsKISS1 protein, humanKisspeptinsLuciferasesRNA, MessengerTCF21 protein, human

Identifiers

PMID21771727
PMCPMC3179423
OpenAlexW2150033601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.